Hostname: page-component-7479d7b7d-767nl Total loading time: 0 Render date: 2024-07-13T07:47:08.850Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence of Antimicrobial Resistance in Acinetobacter calcoaceticus-baumannii Complex in a Saudi Arabian Hospital

Published online by Cambridge University Press:  02 January 2015

Jaffar A. Al-Tawfiq  and
Thangiah X. Mohandhas
Jaffar A. Al-Tawfiq*
Affiliation:
Internal Medicine Services Division, Dhahran Health Center, Saudi Aramco Medical Services Organization, Saudi Aramco, Dhahran, Saudi Arabia
Thangiah X. Mohandhas
Affiliation:
Microbiology Laboratory, Dhahran Health Center, Saudi Aramco Medical Services Organization, Saudi Aramco, Dhahran, Saudi Arabia
*
PO Box 76, Room A-420B, Building 61, Dhahran Health Center, Saudi Aramco, Dhahran 31311, Saudi Arabia (jaffar.tawfiq@aramco.com)
Get access Rights & Permissions [Opens in a new window]

Abstract

During the period from 1998 through 2004, a total of 476 isolates of Acinetobacter calcoaceticus-baumannii complex were recovered. The organism showed high rates of resistance to ampicillin (86% of isolates), cefoxitin (89%), and nitrofurantoin (89%). The rate of resistance to imipenem was 3%; to ticarcillin-clavulanic acid, 16.5%; to gentamicin, 26%; and to ceftazidime, 38%. Multidrug resistance was observed in 14%-35.8% of Acinetobacter species isolates.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 7 , July 2007 , pp. 870 - 872
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.McDonald, LC. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin Infect Dis 2006;42(suppl 2):S65–S71.Google Scholar
2.Crowe, M, Towner, K, Humphreys, H. Clinical and epidemiological features of outbreak of Acinetobacter infection in an intensive therapy unit. J Med Microbiol 1995;43:55–62.Google Scholar
3.Bergogne-Berezin, E, Towner, KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9:148–165.Google Scholar
4.Mah, MW, Memish, ZA, Cunningham, G, Bannatyne, RM. Outbreak of Acinetobacter baumannii in an intensive care unit associated with tracheostomy. Am J Infect Control 2001;29:284–288.CrossRefGoogle Scholar
5.National Committee for Clinical and Laboratory Standards (NCCLS). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard. 6th ed. Wayne, PA: NCCLS; 2003: M7–A6.Google Scholar
6.Eltahawy, AT, Khalaf, RM. Antibiotic resistance among gram-negative non-fermentative bacteria at a teaching hospital in Saudi Arabia. J Chemother 2001;13:260–264.Google Scholar
7.Poirel, L, Menuteau, O, Agoli, N, Cattoen, C, Nordmann, P. Outbreak of extended-spectrum beta-lactamase VEB-l-producing isolates of Acinetobacter baumannii in a French Hospital. J Clin Microbiol 2003;41:3542–3547.Google Scholar
8.Wu, CJ, Lee, HC, Lee, NY, et al.Predominance of gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. J Microbiol Immunol Infect 2006;39:135–143.Google Scholar
9.Ishii, Y, Alba, J, Kimura, S, Yamaguchi, K. Evaluation of antimicrobial activity of beta-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004). Diagn Microbiol Infect Dis 2006;55:143–148.Google Scholar
10.Gales, AC, Jones, RN, Forward, KR, Linares, J, Sader, HS, Verhoef, J. Emerging importance of multi-drug resistant Acinetobacter species and Ste-notrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001;32(suppl 2):S104–S113.Google Scholar
11.Cisneros, JM, Rodriguez-Bano, J, Fernandez-Cuenca, F, et al.Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect 2005;11:874–879.Google Scholar
12.Thongpiyapoom, S, Narong, MN, Suwalak, N, et al.Device-associated infections and patterns of antimicrobial resistance in a medical-surgical intensive care unit in a university hospital in Thailand. J Med Assoc Thai 2004;87:819–824.Google Scholar
13.Pfaller, MA, Sader, HS, Fritsche, TR, Jones, RN. Antimicrobial activity of cefepime tested against ceftazidime-resistant gram-negative clinical strains from North American hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 2006;56:63–68.Google Scholar
14.Mahmood, A, Karamat, KA, Butt, T. Neonatal sepsis: high antibiotic resistance of the bacterial pathogens in a neonatal intensive care unit in Karachi. J Pak Med Assoc 2002;52:348–350.Google Scholar
15.Hart, CA, Kariuki, S. Antimicrobial resistance in developing countries. BMJ 1998;317:647–650.CrossRefGoogle ScholarPubMed